McClung David — SEC Form 4 filings

SEC reporting owner CIK 1686155. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-09-05 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BioCardia, Inc. (BCDA)Chief Financial Officer72 legs · 17,942 sh · $34,99912

Form 4 filings — McClung David

FiledFormIssuerReported transactionsSource
2026-07-074BioCardia, Inc. (BCDA)Tax withholding (F): 23,125 @ $1.24 · Grant/award (A): 41,501 (derivative) @ $0EDGAR
2026-07-014BioCardia, Inc. (BCDA)Grant/award (A): 60,483 @ $1.20EDGAR
2025-12-104BioCardia, Inc. (BCDA)Grant/award (A): 58,276 @ $1.37 · Tax withholding (F): 29,339 @ $1.37 · Grant/award (A): 27,000 (derivative) @ $0EDGAR
2025-07-024BioCardia, Inc. (BCDA)Purchase (P): 4,819 @ $2.08 · Purchase (P): 4,819 (derivative)EDGAR
2025-04-254BioCardia, Inc. (BCDA)Purchase (P): 13,123 @ $1.91 · Purchase (P): 13,123 (derivative)EDGAR
2024-10-164BioCardia, Inc. (BCDA)Grant/award (A): 24,193 @ $2.65 · Tax withholding (F): 11,565 @ $2.65EDGAR
2024-09-054BioCardia, Inc. (BCDA)Grant/award (A): 8,333 @ $3 · Grant/award (A): 8,333 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1686155 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →